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Introduction: Bronchoscopy guidelines address issues of patient and operator safety but do not give guidance on the
expected yield of the procedure. Realistic standards for several outcome measures of bronchoscopy for
investigating bronchial carcinoma have been derived by Scottish clinicians from a published national study. The
present study describes the use of these agreed standards in prospective audit.
Methods: All Society members in Scotland (population 51million) were invited to participate. Data were
collected for 1 year and coded anonymously.
Standards: 1. Supervising bronchoscopist to have completed at least 100 procedures; 2. histology to be positive in
80% of cases where tumour seen; 3. 35%–55% of bronchoscopies to reveal a diagnosis; 4. 60% of patients admitted
for bronchoscopy to be day cases; 5. 80% of day case patients to be in hospital for less than 6 h; 6. 90% of male
patients and 80% of female patients willing to have repeat bronchoscopy.
Results: Three thousand, three hundred and sixteen bronchoscopies were performed by 45 senior pulmonologists
at 22 centres. One centre reached all the standards and five centres met five standards. There was wide national
variation in histological spectrum, incidence of small cell cancer ranged from 12% to 25% between centres.
Participants found their own data helpful in identifying local areas for improvement.
Conclusion: Bronchcoscopy standards set locally by practising pulmonologists can be used in collaborative audit
to identify areas for improving practice. Variation in histology may be accounted for by case-mix or pathology
techniques.
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Fibreoptic bronchoscopy is widely used for investigation of
suspected bronchial carcinoma. Both the British Thoracic
Society (BTS) and American Thoracic Society (ATS) have
published guidelines on the use of bronchoscopy and
recommendations on training (1–3). The BTS guidelines
are concerned primarily with good practice for patient and
sta safety while the ATS guidelines suggest broad
applications and contraindications for the procedure. The
prime aim of fibreoptic bronchoscopy for bronchial
carcinoma is histocytological confirmation but neither of
these guidelines suggests targets for outcomes.Received 8 September 1999 and accepted in revised form 14
December 1999.
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0954-6111/00/050511+05 $35?00/0There is known to be wide variation in clinical practice
among hospitals in the U.K. (4) and North America (5) but
it is not known how this might aect final histocytological
yield. Outcome issues have been investigated in several
studies. Histocytological yield may be dependent on the
technique used, the number of specimens taken (6–8), and
may vary between bronchoscopists (9).
Members of the Scottish Thoracic Society (STS) wished
to examine their performance in bronchoscopy both in
practical aspects of the procedure and also in rates of
histocytological yield. In the absence of national or
international standards on outcomes of bronchoscopy a
previous prospective study had provided realistic standards
by consensus of participating clinicians (10). Respiratory
consultants throughout Scotland were then invited to
participate in a prospective audit using these standards.
The present study describes the use of nationally agreed
audit standards in fibreoptic bronchoscopy to help clin-
icians identify areas of excellence and possible deficiency in
their practice.# 2000 HARCOURT PUBLISHERS LTD
TABLE 1. Number of forms returned from participating
centres
Hospital Hospital
Code n Code n
A 175 O 40
B 0 P 356
C 240 Q 76
D 14 R 120
E 119 S 50
F 147 T 180
G 35 V 422
I 83 W 277
K 184 X 225
L 90 Y 174
M 81 Z 228
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Audit standards were derived from a previous multicentre
prospective study of 1802 bronchoscopies for bronchial
carcinoma which revealed variation in practice, patient
satisfaction and histocytological results (10). Standards
were agreed at a conference attended by most consultant
members of the STS and refined by a Steering Group
formed to encourage bronchoscopy centres in Scotland to
participate in collaborative audit. The steering group was
composed of nine clinicians and one pathologist from nine
centres and represented both university and peripheral
hospitals. These standards were considered by the Group to
be realistic targets which represented good practice in
several important aspects of fibreoptic bronchoscopy. All
senior members of the STS were invited to participate in a
nationwide audit of bronchoscopy practice using the agreed
standards.
BRONCHOSCOPY AUDIT STANDARDS
1. Doctors performing fibreoptic bronchoscopy to have
completed at least 100 previous procedures under
supervision.
2. Where tumour is seen bronchoscopically, aim to
achieve histocytological confirmation in 80%.
3. Between 35–55% of diagnostic bronchoscopies to
confirm bronchial carcinoma should reveal either
macroscopic abnormality or positive cytology.
4. For patients living within 10 miles of the hospital
bronchoscopy should be performed as a day case in
60% (unless the practice of the hospital is to admit for
a complete prospective workup).
5. Aim for 80% of day case patients to be in hospital for
less than 6 h.
6. More than 90% of male patients should be willing to
have repeat bronchoscopy.
7. More than 80% of female patients should be willing to
have repeat bronchoscopy.
The audit was confined to bronchoscopies performed
principally for the diagnosis of suspected bronchial
carcinoma between May 1995 and May 1996. Preprinted
audit forms were completed by medical and nursing sta at
the time of bronchoscopy and histocytological results were
added when available. Patient satisfaction questionnaires
were completed by the patient between 12 and 48 h after the
procedure and either posted or hand-delivered at the next
clinic visit. The data were collected and processed by the
Audit Oce of the Royal College of Physicians and
Surgeons of Glasgow (RCPSG). Results were anonymized
but each participating hospital and physician had access to
their own code.
Results
Forty-five consultant respiratory physicians from 22 centres
participated in the audit representing about 80% of
bronchoscopic activity in Scotland, population 5 128 000(11). Data forms were returned for 3316 bronchoscopies.
Returns for individual centres are shown in Table 1. One
centre (B) did not return any forms.
GRADE OF STAFF PERFORMING
BRONCHOSCOPY
All bronchoscopies were performed or supervised by
doctors who had performed at least 100 bronchoscopies
under supervision.
HISTOCYTOLOGICAL YIELD
Figure 1 shows the percentage of histologically proven
bronchial carcinomas where tumour was visualized. Only
centres where more than 25 tumours were seen are
illustrated.
Figure 2 shows the histological spectrum for each
hospital where more than 20 cancers were diagnosed.
PROPORTION OF ABNORMAL
BRONCHOSCOPIES
Figure 3 shows the proportion of bronchoscopies which
revealed a diagnosis of bronchial carcinoma. Centres which
performed less than 50 procedures are excluded.
LOCAL DAYS CASES
Figure 4 shows percentage of local patients treated as day
patients. One centre did no day case bronchoscopy.
TIME IN HOSPITAL
Twelve centres discharged more than 80% of day cases in
less than 6 h. In two centres less than 20% of day cases were
FIG 1. Percentage of visible tumours confirmed histocytologically.
FIG 2. Histological spectrum of positive biopsy specimens. &: undierentiated; : adenocarcinoma; : oat/small cell;
&: squamous.
FIG 3. Percentage of all bronchoscopies which reveal a diagnosis of cancer.
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FIG 4. Percentage of bronchoscopies as day cases.
514 A. N. MCLEAN ET AL.discharged within 6 h. The mean hospital stay for day case
patients ranged from 3 to 8 h between centres.
PATIENT SATISFACTION
Two centres did not achieve the standard for both male and
female patients and eight centres did not achieve the
standard for females alone.
OVERALL PERFORMANCE
One centre achieved all seven standards and five achieved
six standards.
Anonymized data were made available to all participants
and presented for discussion at a national meeting.
Participants found the standards of value in comparing
their activity against other centres.
Discussion
GRADE OF STAFF PERFORMING
BRONCHOSCOPY
The figure of 100 bronchoscopies was chosen as represent-
ing approximately 1 year of regular bronchoscopy practice
for a trainee in Respiratory Medicine, following which the
doctor would be considered competent in most aspects of
routine fibreoptic bronchoscopy. This compares with a
large North American survey (5) in which 60% of
respondents suggested that trainees need to have performed
more than 50 bronchoscopies to become competent. All
participating centres met the standard, suggesting high
levels of supervision and experience in bronchoscopy
HISTOCYTOLOGICAL YIELD IN VISIBLE
TUMOUR
Three centres were unable to meet this target and one (K)
was well below. Yield from bronchoscopy may vary with
tumour position and operator experience (9) or be due todierences in pathology processing and reporting; centres
with lower yields are required to address the reasons. Some
variation in histological spectrum between hospitals is to be
expected and could be due to case mix or dierences in
reporting. The variation in rates of small cell carcinoma
(SCC) is particularly important as these tumours are
usually chemosensitive and many patients with SCC are
included in national trials.
PROPORTION OF ABNORMAL
BRONCHOSCOPIES
The risk and inconvenience of a procedure is balanced
against the likelihood of a positive or negative finding. A
very high proportion of abnormal bronchoscopies may
suggest under-investigation while a very low proportion
may suggest over-investigation. There was initial diculty
in agreeing this standard and the large variation shown
suggests that it may not be realistic to set a target. Factors
such as individual clinician’s threshold of suspicion, patient
concern and available resources may have too large an
influence to allow a standard to be set.
LOCAL DAY CASES
Patients may be unable to attend as day cases due to
concurrent illness, geographical or social factors. However
a previous Scottish study suggested that 60% of patients
living within a 10 mile radius should be able to go home the
same day (10). In some centres, especially those serving a
wide geographical area, patients attend for a complete
assessment including consultation, chest radiograph,
bronchoscopy and CT scan in a single visit which may
require an overnight stay.
TIME IN HOSPITAL
Some patients will require longer stays than others due to a
variety of factors including transport, general fitness and
availability of friends and relatives to supervise discharge.
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for most patients.
PATIENT SATISFACTION
Reasons for variations in satisfaction are unknown and do
not appear to be related to the sedation technique used nor
to grade of sta performing bronchoscopy (10). There may
be elements in the hospital procedures or infrastructure
which aect patients overall perception of the investigation
and these may lie outwith the clinician’s control. Centres
with low satisfaction scores may need to ask patients more
detailed questions about all aspects of their admission.
Conclusion
Current guidelines on bronchoscopy are consensus docu-
ments from national societies relating to training, indica-
tions for the procedure and good procedural practice (1–3)
They do not address clinical outcome, possibly because of
the diculty in reaching agreement over what constitutes
reasonable results. There can be resistance among clinicians
to accept the validity of guidelines in clinical practice
(12,13). Instead of suggesting further protocols or guide-
lines we have described how physicians can use realistic
procedural and outcome standards, derived from their own
population, to identify areas of excellence and areas for
possible improvement in practice. The study was only
possible due to the sense of ownership engendered by
involving all participants in discussing and setting stan-
dards, and we suggest that this may be more dicult in
larger groups of clinicians or over a wider geographical
area. The authors are not aware of any other published
studies of bronchoscopy comparing outcome results against
peer-approved standards and suggest that the technique
may be applicable to other procedures.
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